secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001104659-25-060637
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron shareholders elect directors, approve board declassification; two supermajority amendments fail
--------------------------------------------------------------------------------

- Class I directors elected: Bassler (87.3M for, 18.6M against), Brown (77.0M for, 28.9M against), Schleifer (99.3M for), Yancopoulos (101.4M for).
- Board declassification amendment approved (85.7M for, 20.2M against, 5.6M broker non-votes).
- Proposal to amend Class A stock conversion supermajority vote failed (0 Class A for, 18.1M against).
- Proposal to remove 80% supermajority for director removal also failed (85.5M for, 20.4M against, not meeting required vote).
- Advisory vote on executive compensation approved (98.8M for, 7.1M against); auditor ratification also passed (105.5M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465925060637/0001104659-25-060637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465925060637/tm2518262d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-060637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer